Introduction
Colorectal cancer (CRC) is the third-leading cancer diagnosed when including both genders, with about 130 000 Americans aected and 56 000 deaths from this disease each year (Landis et al., 1999) . Several studies suggest that nonsteroidal anti-in¯ammatory drugs (NSAIDs), like aspirin and sulindac, have antineoplastic eects. Population-based studies consistently show a 40 ± 50% decrease in the relative risk of colorectal cancer in persons who are continuous users of NSAIDs (Thun et al., 1991) . Studies of patients with familial adenomatous polyposis (FAP), an inherited predisposition for CRC, indicate that celecoxib, a selective COX-2 inhibitor, can reduce both the size and number of colorectal adenomas. Likewise, NSAIDs have been proven to inhibit tumorigenesis in mouse models of intestinal cancer (Jacoby et al., 2000; Oshima et al., 1996; Wechter et al., 1997) , rat models of carcinogen induced colon cancer Rioux and Castonguay, 1998; Yoshimi et al., 1999) and xenografted human carcinomas in nude mice (Nishimura et al., 1999; Sawaoka et al., 1998; Sheng et al., 1997) .
One of the most de®nitively characterized molecular targets of NSAIDs is the cyclo-oxygenase enzyme, which is hypothesized to be involved in the development of colorectal cancer (Oshima et al., 1996; Tsujii and DuBois, 1995) . A large body of evidence suggests that inhibition of COX-2 and the resulting decrease in prostaglandin production may contribute to the anticancer eect of NSAIDs. Consistent with this eect, expression of COX-2 has been evaluated in dierent types of human malignancies and COX-2 levels are increased in intestinal adenomas and adenocarcinomas compared to matched normal mucosa (Eberhart et al., 1994; Williams et al., 1996) . Expression of COX-2 in cultured cells confers a resistance to undergo programmed cell death Tsujii and DuBois, 1995) , promotes angiogenesis Williams et al., 2000a) , stimulates metastatic potential (Tsujii et al., 1997) and modulates proliferation (Kinoshita et al., 1999) . Inactivation of the COX-2 gene in mice is associated with decreased formation of intestinal adenomas (Oshima et al., 1996) with similar eects being seen in prostaglandin E receptor (EP 1 ) knockout mice (Watanabe et al., 1999) . NS-398, a selective COX-2 inhibitor, is reported to suppress tumor growth in dierent types of cancer cell lines (Smith et al., 2000; Tsuji et al., 1996; Yoshimi et al., 1999) . Yoshimi et al. (1999) and Rioux et al. (1998) reported that NS-398 has chemopreventive eects in the AOM induced colon carcinogenesis rat model and NNK-induced lung cancer model. NS-398 was reported to induce apoptosis in human colon carcinoma cells (Hara et al., 1997) , prostate carcinoma cells (Liu et al., 1998) and to have anti-angiogenic eects (Jones et al., 1999; Liu et al., 2000; Tsujii et al., 1998) .
However, other investigators have indicated that COX-2 may not be the only target of NSAIDs. For example, recent evidence suggests that NSAIDs might regulate PPARs (He et al., 1999; Lehmann et al., 1997) , NF-kB signaling (Kopp and Ghosh, 1994; Yin et al., 1998) , and the lipoxygenase pathway (Shureiqi et al., 2000) when given at high doses. Also at high concentrations, NASIDs have anti-proliferative and pro-apoptotic eects on tumor cells that do not contain COX-2 (Hanif et al., 1996; Williams et al., 2000b; Zhang et al., 1999) . It seems that both the COX-2 and non-COX-2 pathways could contribute to the anticancer eect of NSAIDs, which may involve the regulation of apoptosis, cell proliferation, angiogenesis and suppression of metastasis. These other molecular mechanisms by which NSAIDs exert their eects are not clear. Therefore, comparing the precise pattern of gene expression in colon carcinoma cells following NSAID treatment could provide important new information to help understand some of the underlying mechanisms responsible for their anti-neoplastic eect. These eects could be re¯ected in the set genes which are regulated by NSAIDs. Suppression subtractive hybridization (SSH) (Diatchenko et al., 1996) and dierential screening (DS) (Maser and Calvet, 1995) are powerful approaches to identify and isolate cDNAs of dierentially expressed genes (Kuang et al., 1998; von Stein et al., 1997; Zuber et al., 2000) . SSH is a PCR-based subtraction method which selectively ampli®es target cDNA fragments and simultaneously suppresses ampli®cation of non-target cDNAs. Dierential screening is a simple method based on reverse Northern blot analysis. These cloning techniques have the advantage over high density DNA micro-array analysis in that they can detect previously unidenti®ed genes.
We treated HCA-7 cells with NS-398 and then compared the patterns of gene expression between the control and treated cells. Our experimental approach combined the advantages of SSH plus DS and allowed for rapid identi®cation of dierentially expressed genes which excluded isolation of false positive and false negative clones by SSH.
Results
We found signi®cant inhibition of HCA-7 cell growth following treatment with NS-398 (Figure 1 ). To evaluate this process more carefully, we employed SSH to study changes in gene expression following treatment. Cells were treated with 100 mM of NS-398 for 4 days and then harvested for mRNA isolation. SSH and DS were performed as shown in the¯ow diagram (Figure 2) . To isolate sequences which are downregulated following NS-398 treatment, we used tester cDNA prepared from drug treated mRNA and Oncogene Genes regulated by NSAIDs Z Zhang and RN DuBois excess driver cDNA from control mRNA samples (forward subtraction). To recover sequences upregulated upon NS-398 treatment, we used control cDNA as tester and cDNA from drug treated sample as driver (reverse subtraction). Using SSH, we identi®ed a total of 57 cDNAs. Twenty-eight clones were obtained from the forward subtraction and twenty-nine clones from the reverse subtraction.
After hybridization, we measured the subtraction eciency by using PCR to amplify GAPDH, a known housekeeping gene. As shown in Figure 3 , two rounds of subtraction had a very high eciency of removing background sequences. The GAPDH band appeared after 33 cycles with the subtracted products as template, while a signal was detected after only 18 cycles using template from the non-subtracted samples.
In general, the SSH technique had some background that could lead to false positives. Therefore, randomly picking clones from the subtracted library for Northern blot analysis would be time consuming and inecient. We found that performing the DS step helps minimize the background before embarking on an evaluation of the expression status of each individual gene. To perform DS, we arrayed all the duplicate clones in each ®lter and hybridized the ®lter separately with the total secondary PCR ampli®ed products from the forward and reverse SSH as probes. The results from this screen are illustrated in Figure 4 . We classi®ed a clone as positive only when it showed a greater than 3 ± 4-fold dierence in expression.
We identi®ed 42 dierentially expressed cDNAs and compared their sequence to those reported in the available GenBank/EMBL databases online. We found 23 novel cDNA fragments, while 19 clones had some homology to gene sequences reported in the database. We evaluated these 19 clones by Northern blot analysis of total RNA obtained from treated and control HCA-7 cells. Of these, 12 clones were dierentially expressed ( Figure 5 and Table 1 ).
Among the genes that were down-regulated by NS-398, we designated one as NRG-1 (NSAID Regulated Gene 1) which is also known as KIAA0101 (Nagase et al., 1995) . Additional COX-2 inhibitors have been developed and are reported to have anti-neoplastic eects. To determine if NRG-1 is regulated by other NSAIDs we examined the eect of SC-58125, sulindac sul®de, and nemisulide on gene expression in HCA-7 cells. As shown in Figure 6a , all of these agents reduced NRG-1 mRNA levels from 3 ± 20 fold. We also evaluated the expression of NRG-1 in human colon cancers and matched normal tissues. Among the six pairs of human colon cancers and the related normal mucosal samples, ®ve pairs showed high levels of NRG-1 expression in colon carcinomas compared to adjacent normal mucosa (Figure 6b ).
Discussion
Many dierent techniques have been developed to obtain an inventory of dierential transcripts between two populations of mRNAs. Identi®cation and isolation of dierentially expressed transcripts is generally achieved by one of the following methods: dierential display (DD) and related techniques (Liang and Pardee, 1992) ; representational dierence analysis (RDA) (Lisitsyn et al., 1993) ; enzymatic degradation subtraction (Zeng et al., 1994) ; techniques involving physical removal of common sequences (Akopian and Wood, 1995; Deleersnijder et al., 1996) ; suppression subtractive hybridization; dierential screening or Figure 4 Dierential screening cDNA clones from SSH. After PCR ampli®cation and denaturation, the cDNA fragment of each clone obtained by SSH was arrayed in duplicate on each blot. The blots were then hybridized with probes made from the total PCR products from SSH. Blot A was hybridized with probes from forward SSH and blot B with probes from reverse SSH (A2-10, B1-10 and C1-10 are cDNA clones from forward SSH. D1-10, E1-10 and F1-9 are cDNA clones from reverse SSH. A1 and F10 are negative controls) cDNA micro-array analysis (Drmanac and Drmanac, 1999) . Despite the fact that all these methods have proven successful in the isolation of dierentially expressed genes, they all possess some intrinsic drawbacks. SSH combines subtractive hybridization with suppression PCR to generate a population of PCR fragments enriched for sequences from genes that are dierentially expressed. The strength and novelty of SSH stems from a process called normalization, which equalizes the wide dierences in abundance of dierent mRNA species. This allows for the recovery of abundantly expressed transcripts (i.e. those encoding cytoskeletal proteins), and of low-copy-number mRNAs (i.e. those encoding transcription factors). Compared to other methods which restrict the analysis only to dierences at the 3'-end of cDNAs or require multiple rounds of subtraction, SSH is simple and covers all the portions of the cDNA sequence. Beside this, SSH also results in the isolation of relatively long cDNA sequences, sucient to permit database searching for homology to common motifs of predicted translation products.
Among the known genes we identi®ed, some belong to the cadherin superfamily, which is a family of singletransmembrane calcium-dependent cell adhesion proteins. Some of the genes we identi®ed regulate cell cycle progression and several are involved in signaling pathways which control apoptosis and dierentiation.
Human FAT (Mahoney et al., 1991) and PCDH7 (Yoshida et al., 1998) , which are up-regulated following treatment, are members of the cadherin family. Figure 5 Northern blot analysis of dierentially expressed genes. cDNA fragments were used as probes for Northern blot analysis of total RNA isolated from control and NS-398 treated HCA-7 cells. Northern blotting was performed as described in the Materials and methods section. GAPDH was used as loading control. (N, NS-398 treatment; D, DMSO control) The dierential expression of all the genes listed was con®rmed by dierential screening and Northern blotting. Down: indicates decreased levels following treatment; Up: indicates increased levels following treatment. The number in parentheses is the fold increase or decrease after treatment Figure 6 NRG-1 expression in HCA-7 cells and human tissues.
(a) NS-398 (100 mM), SC-58125 (100 mM), sulindac sul®de (25 mM), and nimesulide (100 mM) were added to HCA-7 cells for 4 days. (b) Six pairs of human colon carcinoma and matched normal mucosa was analysed in the experiment. Total RNA isolation and Northern blot analysis was performed as described in Materials and methods section. 18s RNA was used as loading control
De®ning mechanisms involved in cadherin-mediated cell-cell adhesion is at the core of understanding a diverse range of cellular phenomena. The human FAT gene is homologous to Drosophila fat, a tumor suppressor gene which is essential for controlling cell proliferation during Drosophila development. Mutations in the FAT gene lead to a cell autonomous overgrowth phenotype (Dunne et al., 1995) . Cyclin K was found to be down-regulated following treatment with NS-398. This is a new member of thè transcription' cyclin family and most closely related to human cyclin C and H. It was reported that cyclin K plays a dual role in regulating Cdk and RNAP-2 activity (Edwards et al., 1998) . Another gene involved in the regulation of cell proliferation is the p100 gene, which codes for a novel proliferation-associated nuclear protein. P100 protein is exclusively expressed in proliferating cells and speci®cally restricted to the S, G2, and M phase o the cell cycle (Heidebrecht et al., 1997) .
Pdcd4, Dynamin 2 and LIP.1 are all up-regulated by NS-398 in HCA-7 cells. Pdcd4 is homologous to a mouse apoptosis related gene, MA-3. MA-3 was found in many apoptosis-inducible cell lines, including thymocytes, T cells, B cells and pheochromocytoma (Shibahara et al., 1995) . More recently, Cmarik et al. (1999) reported that the pdcd4 protein inhibits neoplastic transformation in mouse JB6 cells. Dynamin 2 is a ubiquitously expressed isoform of dynamin which is a member of the GTPase superfamily. Fish et al. (2000) reported that an increase of dynamin 2 activates p53 and induces apoptosis in a p53 dependent fashion. LIP.1 is a cytoplasmic 160 KD phosphoserine protein which binds to the LAR membrane-distal D2 protein tyrosine phosphatase domain and appears to localize at focal adhesions. LAR is a widely expressed receptorlike protein tyrosine phosphatase that is implicated in regulation of intracellular signaling triggered by both cell adhesion and peptide growth factors (Serra-Pages et al., 1995). Wang et al. (2000) indicated that LAR can inhibit FGF-induced MAPK activation by inhibiting the tyrosine phosphorylation of signal transducers that act downstream of the FGF receptor and the overexpression of LAR in mammalian cells induces caspase-dependent apoptosis (Weng et al., 1999) .
ENH is a LIM protein whose levels are increased following NS-398 treatment. LIM contains a cysteinerich domain composed of two independent zinc-®nger domains which has been proposed to direct proteinprotein interactions. ENH contains three LIM domains in the C-terminal region and was shown to be associated with PKC in an isoform speci®c manner in vivo and was phosphorylated by PKC in vitro (Kuroda et al., 1996) . The function of ENH is not clear, but recently Nakagawa et al. (2000) reported that ENH may play an important role in heart development.
NRG-1, reported as KIAA0101, was ®rst cloned from a cDNA library made from human KG-1 myeloid cells (Nagase et al., 1995) . NRG-1 contains an open reading frame encoding 111 amino acids that has no homology to any known protein.
In this study, we demonstrated that NRG-1 is down regulated following treatment with several dierent NSAIDs and its levels are higher in human colon cancers compared to normal tissue. NRG-1 is also induced by K-ras in rat intestinal epithelial cells (data not shown). NRG-1 may represent a downstream gene regulated by NSAIDs that is involved in anti-neoplastic eects of NSAIDs. A functional study of NRG-1 is underway and it may serve as a useful biological marker for the presence of a colorectal carcinomas or adenomas in humans.
The results of our study provide evidence that the anti-neoplastic eects of high dose NSAIDs is a complex process which may be due to alterations in the expression of genes which regulate a number of biological processes. Further studies are underway to determine the precise function of novel genes we have identi®ed and which genes are essential for the chemopreventive and chemotherapeutic eects of NSAIDs.
Materials and methods

Cell culture
The HCA-7 cells, which are derived from a rectal carcinoma, were kindly provided by Dr Susan Kirkland (ICRF, London, UK). Cells were cultured at 378C with 5% CO 2 in McCoy's 5A medium containing penicillin, streptomycin, 10% FBS (Life Technologies, Inc., Grand Island, NY, USA). NS-398 and nimesulide (Cayman chemicals, Ann Arbor, MI, USA), sulindac sul®de (Merck & Co., Rahway, NJ, USA) and SC-58125 (GD Searle Co., St. Louis, MO, USA) were dissolved in DMSO prior to addition to cell culture medium. Experimental controls were treated with 0.1% DMSO.
mRNA isolation
Total cellular RNA was isolated using Tri-Reagent (Molecular Research Center, Inc., Cincinnati, OH, USA) and polyadenylated RNA was isolated using a mRNA Puri®ca-tion Kit (Amersham Pharmacia Biotech, Inc., Piscataway, NJ, USA).
Suppression subtractive hybridization
SSH was performed with the PCR-Select TM cDNA Subtraction Kit (Clontech Laboratories Inc., Palo Alto, CA, USA) as described by the manufacturer except for slight modi®ca-tions of the PCR and hybridization conditions. Starting material consisted of 2 mg of mRNA from NS-398 treated HCA-7 cells and 2 mg of mRNA from control cells. After synthesis of the ®rst and second cDNA strands, the cDNA was digested with RsaI to obtain shorter, blunt-ended molecules. Then ligation of two dierent adapters to the cDNA fragments was performed separately. The adapter sequences were as follows: 5'-CTAATACGACTCACTA-TAGGGCTCGAGCGGCCGCCCGGGCAGGT-3' (adapter 1) and 5'-CTAATACGACTCACTATAGGGCAGCGTGG-TCGCGGCCGAGGT-3' (adapter 2R). For the ®rst round hybridization, the mixture of driver and tester cDNA were denatured at 988C for 1.5 min and then maintained at 688C for *10 h. For the second round hybridization, driver cDNA was denatured at 988C for 1.5 min and then added to the mixture of the two previous hybridization and allowed to incubate at 688C for *18 h.
After two rounds of hybridization, two rounds of PCR were performed to amplify the speci®c, dierentially expressed cDNA fragments. All PCR reactions were performed using a PTC-100 thermal cycler (MJ Research, Inc. Watertown, MA, USA). The primer used in ®rst round is 5'-CTAATACGACTCACTATAGGGC-3' (primer 1) and the primers used in second round were 5'-TCGAGCGGCCGCC-CGGGCAGGT-3' (nested primer 1) and 5'-AGCGTGGTC-GCGGCCGAGGT-3' (nested primer 2R). Cycling parameters are as follows: for the ®rst round, 27 cycles of 948C for 30 s, 648C for 30 s and 718C for 1.5 min; for the second round, 15 cycles of 948C for 30 s, 688C for 30 s and 728C for 1.5 min.
To evaluate subtractive eciency, the same amount of subtracted and unsubtracted secondary PCR products were applied as templates, and GAPDH primers were used to perform PCR. The PCR products were examined in a 2.0% agarose/EtBr gel to detect the abundance of GAPDH. After evaluation of the subtractive eciency, the subtracted PCR products were cloned directly into the pCR2.1-TOPO vector (In Vitrogen, Carlsbad, CA, USA). Plates were incubated at 378C until small clones were visible and the blue/white staining could be clearly distinguished.
Differential screening
DS was performed by using the PCR-Select TM Dierential Screening Kit (Clontech) according to the users manual. After picking the recombinant clones from the subtractive library and identifying them by restriction digestion, the insert was PCR ampli®ed in 20 ml volume reactions using nested PCR primer 1 and 2R. After ampli®cation, 5 ml of the PCR product was denatured with 5 ml of 0.6 N NaOH and then 1.5 ml of each mixture was transferred to a nylon membrane. Each cDNA fragment was arrayed in duplicate in each blot and two identical blots were prepared for hybridization with dierent probes. The total secondary PCR ampli®ed products from the forward and reverse SSH were used as probes. After washing, the membranes were exposed overnight to Kodak BioMax MR X-ray ®lm (Eastman Kodak Company, Rochester, NY, USA) with and intensifying screen at 7708C.
Northern blotting
Total cellular RNA samples (*30 mg/lane) were denatured and fractionated in 1% formaldehyde-agarose gels and then blotted to nylon ®lters. The blots were hybridized with cDNA probes labeled with a-32 P-dCTP by using a Prime-It random prime labeling kit (Stratagene, La Jolla, CA, USA). A GAPDH probe was used as an internal control to determine the variability of loading among lanes.
Sequencing analysis
Sequencing of cDNA inserts was accomplished in the DNA Sequencing Core Lab of Vanderbilt-Ingram Cancer Center. Sequence homology searches were conducted using BLAST program against the NCBI databases (http://www.ncbi.nim.-nih.gov/).
